These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26577454)

  • 1. Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
    Madka V; Mohammed A; Li Q; Zhang Y; Biddick L; Patlolla JM; Lightfoot S; Towner RA; Wu XR; Steele VE; Kopelovich L; Rao CV
    Cancer Prev Res (Phila); 2016 Jan; 9(1):53-62. PubMed ID: 26577454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.
    Madka V; Zhang Y; Li Q; Mohammed A; Sindhwani P; Lightfoot S; Wu XR; Kopelovich L; Rao CV
    Neoplasia; 2013 Aug; 15(8):966-74. PubMed ID: 23908596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma.
    Madka V; Mohammed A; Li Q; Zhang Y; Kumar G; Lightfoot S; Wu X; Steele V; Kopelovich L; Rao CV
    Am J Cancer Res; 2015; 5(10):3030-41. PubMed ID: 26693057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.
    Madka V; Mohammed A; Li Q; Zhang Y; Patlolla JM; Biddick L; Lightfoot S; Wu XR; Steele V; Kopelovich L; Rao CV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):708-16. PubMed ID: 24795386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder.
    Jin S; Chang IH; Kim JW; Whang YM; Kim HJ; Hong SA; Lee TJ
    J Korean Med Sci; 2017 Aug; 32(8):1327-1336. PubMed ID: 28665070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.
    Makhlin I; Zhang J; Long CJ; Devarajan K; Zhou Y; Klein-Szanto AJ; Huang M; Chernoff J; Boorjian SA
    BJU Int; 2011 Jul; 108(2 Pt 2):E84-90. PubMed ID: 21050361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of p53 and Pten promotes invasive bladder cancer.
    Puzio-Kuter AM; Castillo-Martin M; Kinkade CW; Wang X; Shen TH; Matos T; Shen MM; Cordon-Cardo C; Abate-Shen C
    Genes Dev; 2009 Mar; 23(6):675-80. PubMed ID: 19261747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.
    Hansel DE; Platt E; Orloff M; Harwalker J; Sethu S; Hicks JL; De Marzo A; Steinle RE; Hsi ED; Theodorescu D; Ching CB; Eng C
    Am J Pathol; 2010 Jun; 176(6):3062-72. PubMed ID: 20395440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.
    Ayala de la Peña F; Kanasaki K; Kanasaki M; Tangirala N; Maeda G; Kalluri R
    J Biol Chem; 2011 Jun; 286(23):20778-87. PubMed ID: 21388952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.
    Liu Z; Song L; Xie J; Wu XR; Gin GE; Wang B; Uchio E; Zi X
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
    Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
    Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
    Chi BH; Kim SJ; Seo HK; Seo HH; Lee SJ; Kwon JK; Lee TJ; Chang IH
    J Korean Med Sci; 2015 Mar; 30(3):308-16. PubMed ID: 25729255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.
    Zhou H; Huang HY; Shapiro E; Lepor H; Huang WC; Mohammadi M; Mohr I; Tang MS; Huang C; Wu XR
    Carcinogenesis; 2012 Apr; 33(4):770-80. PubMed ID: 22287562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder.
    Gonzalez-Roibon ND; Chaux A; Al-Hussain T; Osunkoya AO; Bezerra SM; Hicks J; Epstein JI; Netto GJ
    Hum Pathol; 2013 Apr; 44(4):612-22. PubMed ID: 23084634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
    Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
    Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
    Alayev A; Salamon RS; Schwartz NS; Berman AY; Wiener SL; Holz MK
    J Cell Physiol; 2017 Feb; 232(2):436-446. PubMed ID: 27225870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
    Nishikawa M; Miyake H; Behnsawy HM; Fujisawa M
    Urol Oncol; 2015 Apr; 33(4):166.e9-15. PubMed ID: 25618298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
    Liu Z; Xu X; Li X; Liu S; Simoneau AR; He F; Wu XR; Zi X
    Cancer Prev Res (Phila); 2013 Dec; 6(12):1365-75. PubMed ID: 24121102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.